Loader
Please Wait
Applying Filters...

Acharya Chemicals KS Header Acharya Chemicals KS Header

X

Overview of custom API manufacturing services, from pre-clinical & clinical manufacturing to commercial manufacturing, offered by CDMOs, CMOs, & CROs.

Filters Filter
Cross PopUp
FILTER :

filter

01 Custom Synthesis

02 Custom Synthesis

03 Custom Synthesis

04 Custom Synthesis

05 Custom Synthesis

06 Custom Synthesis

07 Custom Synthesis

08 Overview

09 Overview

10 Overview

11 Overview

12 Overview

13 Overview

14 Overview

15 Overview

16 Overview

17 Overview

18 Overview

19 Overview

20 Overview

21 Overview

22 Overview

23 Overview

24 Overview

25 Overview

26 Route Scouting

27 Route Scouting

filter

01 Acharya Chemicals

02 Anacipher

03 Angelini Pharma

04 Aozeal Certified Standards

05 Arevipharma

06 Avra Laboratories

07 Axplora

08 Bachem AG

09 BioSpectra

10 CBL- Chemical and Biopharmaceutical Laboratories

11 CPL Sachse

12 CRMO Pharmmatecch

13 CTX Lifesciences

14 Cambrex Corporation

15 Cayman Chemical Company Inc

16 ChemCon GmbH

17 ChemGenix Laboratories Pvt Ltd

18 Chemtos

19 Curia

20 DOTTIKON EXCLUSIVE SYNTHESIS AG

21 Dalton Pharma Services

22 Diverchim S.A.

23 EUROAPI

24 Evonik

25 Huvepharma Italia S.r.l

26 Inabata France S.A.S

27 Infinium Pharmachem

28 Inke S.A

29 Kekule Pharma

30 LEBSA

31 Legacy Pharmaceuticals Switzerland

32 M2i Group

33 Maithili Life Sciences

34 Malladi Drugs & Pharmaceuticals Limited

35 Menadiona

36 Merck Millipore

37 Minakem

38 Neuland Laboratories

39 Olon S.p.A

40 PMC Isochem

41 Pfanstiehl

42 Polpharma

43 Priyans Drugs

44 Procos

45 Quality Chemicals

46 Quotient Sciences

47 Recipharm AB

48 Robinson Brothers

49 ScinoPharm Taiwan, Ltd

50 Seqens

51 Servier

52 Shanghai Chemspec Corporation

53 Siegfried AG

54 Solara Active Pharma Sciences

55 Stason Pharmaceuticals, Inc.

56 TOPCHEM PHARMACEUTICALS

57 Valsynthese

58 ZACH System SA

filter

01 Canada

02 China

03 France

04 France

05 France

06 France

07 France

08 France

09 France

10 France

11 Germany

12 Germany

13 Germany

14 Greece

15 India

16 India

17 India

18 India

19 India

20 Ireland

21 Italy

22 Poland

23 Singapore

24 Spain

25 Spain

26 Spain

27 Sweden

28 Switzerland

29 Switzerland

30 Switzerland

31 Taiwan

32 U.S.A

33 U.S.A

34 United Kingdom

35 United Kingdom

List of Learn MoreList of #LearnMore
Close
4

Overview of custom API manufacturing services, from pre-clinical & clinical manufacturing to commercial manufacturing, offered by CDMOs, CMOs, & CROs.

Q1. What is custom API manufacturing?

Custom API manufacturing refers to the production of desired quantities of pharma APIs, intermediates, fine chemicals, small molecules, reference standards, impurities, and other drug substances. API production is carried out exclusively according to a specified scale, which may include large scale custom API capabilities or commercial scale APIs.

The amounts produced during drug substance custom manufacturing tend to be small, ranging from a few milligrams to about 10 kg or so, and can be carried out in-house or by contract active pharmaceutical ingredient manufacturers. An active pharmaceutical ingredient (API) is any substance or mixture of substances intended to be used as active ingredients in medicinal drug products. Active ingredients have direct effects in the diagnosis, cure, mitigation, treatment, and prevention of diseases.

Pharma APIs and raw materials are often confused due to the similar usage of the two terms, however, raw materials refer to the chemical compounds used as a base for API production. The API production process is not completed in a single step, but rather via several chemical reactions between raw materials. The chemical compound which is in the process of becoming an API from a raw material is called an intermediate.

Intermediates are the building blocks of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates are by-products of API synthesis. Furthermore, these pharmaceutical intermediates are produced during each and every reaction of API synthesis. The intermediates are then used in API production for bulk drugs and also for contract research and development (R&D) purposes by various pharma companies.

Fully integrated contract development and manufacturing organizations offer cGMP API manufacturing services from small scale cGMP contract manufacturing of API to large scale custom API capabilities. Many of the CDMOs and CMOs offer small scale cGMP contract manufacturing of active pharmaceutical ingredients or custom synthesis of small molecules as a contract research project or as a custom synthesis project.

The integrated cGMP API manufacturing services allow small scale cGMP contract manufacturing of APIs, from inception all the way through to clinical custom manufacturing and can even advance to production at a commercial scale. Custom API manufacturing or drug substance custom manufacturing ultimately provides the platform necessary for clients to accelerate time to market for finished dosage forms (FDF).

Various pharmaceutical contract development organizations (CDMOs) can take projects from initial process development and scale-up through final validation and manufacturing at a commercial scale, by applying the appropriate drug manufacturing strategies and custom API manufacturing services. Custom API manufacturing services involve - Manufacturing of High Potent APIs (HPAPIs) or HPAPI custom synthesis, Key Starting Materials (KSMs), Registered Starting Materials (RSMs), key GMP intermediates, commercial scale APIs, etc.

Q2. What are the different capabilities involved in drug substance or API custom manufacturing?

Drug Manufacturing Strategies Involved in API Custom Manufacturing

Step 1: Physicochemical Studies In this stage of API synthesis, the physicochemical properties of a drug substance are characterized and established. Every drug substance has intrinsic chemical and physical properties which need to be considered before latter drug manufacturing strategies can be conducted at a larger scale.

Physicochemical studies include:

- Selection of suitable drug substance candidates for API production
- Planning API and drug substance custom development & manufacturing processes
- Advancement of analytical development cGMP API manufacturing services
- Assignment of pharma API retest periods
- Synthetic route scouting custom API manufacturing services

 

Route Scouting & Route Optimization:

Synthetic route scouting, during early stages of process development and drug manufacturing, offers significant benefits by decreasing processing times, reducing the steps involved in process chemistry, improving quality and safety profiles, reducing chemical waste production, and improving scalability. 

Route optimization can reduce costs, increase the efficiency of drug substance cGMP manufacturing, increase the safety of drug products, and accelerate the drug substance custom development and manufacturing process altogether. 

Custom synthesis and route scouting go hand in hand, lately there has been an increasing trend towards achieving route optimization and all the benefits that the custom API manufacturing service imparts to the pharmaceutical product development process. Contract manufacturers provide such process chemistry, route scouting and route optimization - discovery and development services. 

 

Step 2: Selection of Raw material: Active pharmaceutical ingredient (API) manufacturers take the raw materials, chosen during the early stages of drug substance development, and treat them in a reactor to obtain the required intermediates. 

Step 3: Intermediates are purified to obtain individual drug products via sedimentation, filtration, centrifugation, crystallization, etc. 

Step 4: Standards- The products that are obtained as a result are checked for their strength. Each pharmaceutical company employs different standards to measure the strength of its API.

Step 5: Physicochemical studies, reactor treatments, and purification are followed by scale-up custom API manufacturing services. Scale up is generally defined as the process of increasing batch sizes. In process scale up, a formula is transformed into a viable, robust product by the development of a reliable and practical method of manufacturing that affects the orderly transition from laboratory to routine processing of commercial scale APIs in a full-scale production CDMO facility. 

Q3. What are the key features of cGMP API manufacturing?

Good manufacturing practices (GMP) and to be GMP certified means that the active pharmaceutical ingredient (API) manufacturer has demonstrated a strong regulatory commitment compliant with international GMP standards. The jump to cGMP manufacturing is never simple, producing complex molecules within specification for the first time in cGMP is fraught with potential peril at every turn.

API production has traditionally been done by pharmaceutical companies themselves in their home countries, but in recent years many corporations have opted to outsource manufacturing overseas to various CDMOs and CMOs. All the drug manufacturing strategies from selection of raw materials to commercial manufacturing of pharma APIs are performed under cGMP (current Good Manufacturing Practices) conditions.

GMP is followed to ensure that pharmaceutical products (drug substances or drug products) are consistently produced and controlled according to quality standards and to minimize the risks involved in pharmaceutical production. Key elements of GMP API manufacturing must be clearly defined, agreed and controlled in order to avoid misunderstandings which could result in unsatisfactory products.

 

Key Elements in GMP API Contract Manufacturing:

- Quality Agreement
- Adherence to manufacturing process
- Supplier Audit
- Release of manufactured product
- Documentation and archive
- Cleaning Validation
- Change control

Q4. What are the key attributes when performing cGMP scale up in custom API manufacturing?

Drug substances are needed for a large number of safety studies and clinical trials. Custom synthesis and manufacturing services to go from preclinical to clinical manufacturing, and finally to commercial manufacturing can be challenging.

It is essential that the drug substance manufacturing process, called scale up, is carried out to produce large quantities of active pharmaceutical ingredients. Additionally, when progressing a drug substance from milligram to kilogram scale, there are various characteristics of the drug substance that can impact formulation and need to be considered prior to implementing scale up.

Pharmaceutical GMP scale-up deals with a subject vitally important to the industry—the procedures of transferring the results obtained via discovery and development services, from laboratory scale to the pharmaceutical pilot unit, and finally to production scale under GMP (Good Manufacturing Practices) conditions.


Laboratory Scale: The early stage development phase, generally 100-1000 times lesser in quantity (milligrams) as compared to the production batch, takes place during the laboratory scale stage of formulation scale-up. 

Pilot Plant: It is used to test the behavior of a product during small scale custom API development and manufacturing, before proceeding with large scale custom API capabilities at a commercial scale. Pilot labs often use kilo lab units to achieve low volume, test batches of active pharmaceutical ingredients.
It is also an important stage for hazard identification and toxicity testing of drug products in a quality controlled testing laboratory. The pilot plant stage is where a lab scale formula is transformed into a viable product by using practical custom synthesis services and manufacturing procedures.

GMP Production Scale: The last stage of scale-up (kilogram stage) is the production scale. Production batches are referred to as the 100X batch and this is the scale at which fully integrated contract research organizations, and more importantly contract development and manufacturing organizations, run during routine marketing of products.

Fully integrated contract manufacturers, for API and molecule development, have the custom synthesis expertise to provide GMP scale up services at the laboratory and pilot scale of drug development.

First
Last

Post Enquiry
POST ENQUIRY